The dust has settled on the initial frenzy around generative AI. And pharma’s legacy enterprise systems can dull even the most exciting technology. Time for a sober reassessment, where we determine how to better meet evolving HCP expectations and secure lasting customer satisfaction. Cut through the noise and listen to how generative AI can be harnessed to fit our unique potential into performance.

Panel: Myles Furnace; Karsten Friederich; Yahya Anvar
Moderator: Paul Simms

scroll down to listen to the recording

---